Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
OMB No. 0651-0009 (Exp 02/28/2021) |
Serial Number: 88935765 |
Filing Date: 05/27/020 |
Input Field |
Entered |
SERIAL NUMBER | 88935765 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\889\357\88935765\xml1\ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | MNG LABORATORIES |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a horizontal helix figure above MNG in bold capital letters and LABORATORIES in nonbold capital letters. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 384 x 512 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Laboratory Corporation of America Holdings |
*MAILING ADDRESS | 531 South Spring Street |
*CITY | Burlington |
*STATE (Required for U.S. applicants) |
North Carolina |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
27215 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Molecular and metabolic genetic testing for research purposes and consultation services related thereto. |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 09/01/2015 |
FIRST USE IN COMMERCE DATE | At least as early as 09/01/2015 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-7176204214-20200527105400991687_._Home_-_mnglabscom_2020-05-27T14-35-37.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0004.JPG | |
ORIGINAL PDF FILE | SPE0-7176204214-20200527105400991687_._About-Us-mnglabscom_2020-05-27T14-37-54.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0005.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0006.JPG | |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0007.JPG | |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0008.JPG | |
ORIGINAL PDF FILE | SPE0-7176204214-20200527105400991687_._testing-mnglabscom_2020-05-27T14-36-43.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0009.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0010.JPG | |
ORIGINAL PDF FILE | SPE0-7176204214-20200527105400991687_._Programs-mnglabscom_2020-05-27T14-37-28.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0011.JPG |
SPECIMEN DESCRIPTION | webpages |
INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | medical testing for diagnostic, treatment and screening purposes; Molecular and metabolic genetic testing for medical purposes and consultation services related thereto. |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 09/01/2015 |
FIRST USE IN COMMERCE DATE | At least as early as 09/01/2015 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-1-7176204214-20200527105400991687_._Home_-_mnglabscom_2020-05-27T14-35-37.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0012.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0013.JPG | |
ORIGINAL PDF FILE | SPE0-1-7176204214-20200527105400991687_._About-Us-mnglabscom_2020-05-27T14-37-54.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0014.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0015.JPG | |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0016.JPG | |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0017.JPG | |
ORIGINAL PDF FILE | SPE0-1-7176204214-20200527105400991687_._testing-mnglabscom_2020-05-27T14-36-43.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0018.JPG |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0019.JPG | |
ORIGINAL PDF FILE | SPE0-1-7176204214-20200527105400991687_._Programs-mnglabscom_2020-05-27T14-37-28.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT18\889\357\88935765\xml1\APP0020.JPG |
SPECIMEN DESCRIPTION | webpages |
ATTORNEY INFORMATION | |
NAME | William M. Bryner |
ATTORNEY DOCKET NUMBER | 1189326 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Kilpatrick Townsend & Stockton LLP |
STREET | 1001 West Fourth Street |
CITY | Winston-Salem |
STATE | North Carolina |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 27101 |
PHONE | 336-607-7300 |
FAX | 3366077500 |
EMAIL ADDRESS | tmadmin@kilpatricktownsend.com |
OTHER APPOINTED ATTORNEY | Laura C. Miller, Tiffani D. Otey and any other attorney with the firm |
CORRESPONDENCE INFORMATION | |
NAME | William M. Bryner |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | tmadmin@kilpatricktownsend.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | kfrith@kilpatricktownsend.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 275 |
*TOTAL FEES DUE | 550 |
*TOTAL FEES PAID | 550 |
SIGNATURE INFORMATION | |
SIGNATURE | /Kathryn W. Kyle/ |
SIGNATORY'S NAME | Kathryn W. Kyle |
SIGNATORY'S POSITION | Senior Vice President and Assistant Secretary |
SIGNATORY'S PHONE NUMBER | 336-436-5021 |
DATE SIGNED | 05/27/2020 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
OMB No. 0651-0009 (Exp 02/28/2021) |
Serial Number: 88935765 |
Filing Date: 05/27/020 |
The applicant's current Correspondence Information: |
William M. Bryner |
PRIMARY EMAIL FOR CORRESPONDENCE: tmadmin@kilpatricktownsend.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kfrith@kilpatricktownsend.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|